Updated

Biotech startup Intero Biosystems is commercializing lab-grown human intestinal organoids to pharmaceutical companies as regulators increasingly push for alternatives to animal testing in drug development. The company is working to scale production of its organoid technology, offering drugmakers a more physiologically accurate testing platform that could accelerate development timelines and reduce reliance on animal models.